SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Additional Details For OAI Classification For Halol Facility
Additional details for OAI classification for Halol facility. This is for your information and further dissemination. Thanking you,29-03-2020
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Additional Details For OAI Classification For Halol Facility
Additional details for OAI classification for Halol facility. This is for your information and further dissemination. Thanking you,SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Update On Halol Facility
Update on Halol facility This is for your information and records. Thanking you,SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed herewith our Press Release relating to the donation of medicines and hand sanitizers to support India's COVID-19 pandemic response, which we shall be releasing after sending this letter to you. This is for your information and record. Thanking you,SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 25, 2020 for Aditya Medisales Limited.SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of Corrigendum to Public Announcement issued in relation to the buy-back of equity shares by Sun Pharmaceutical Industries Limited ('Company')SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Public Announcement-Buyback of Shares
Submission of Corrigendum to Public Announcement issued in relation to the buy-back of equity shares by Sun Pharmaceutical Industries Limited ('Company')SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 25, 2020 for Raksha Sudhir Valia.SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 25, 2020 for Shanghvi Finance Private Limited.SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Closure of Trading Window
This is to inform you that in compliance with the Company's Code of Conduct for prevention of Insider Trading, the window closure for trading by Designated Persons of the Company shall be with effect from Wednesday, 1st April, 2020 till 48 hours after the declaration of Financial Results of the Company for the quarter and year ended 31st March, 2020. The date of the Board Meeting of the Company for declaration of financial results for the quarter and year ended on 31st March, 2020 will be intimated in due course.SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Public Announcement-Buyback of Shares
Filing of Public Announcement for Buy-back of equity shares by the Company pursuant to the provisions of Regulation 16 of the SEBI (Buy-Back of Securities) Regulations, 2018 and Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015